Phase 2 Trial of a Novel COPD Treatment - a podcast by American Thoracic Society

Drs. Stephen Rennard and Shawn Aaron discuss a manuscript from Dr. Rennard and his colleagues about using the CXCR2 antagonist MK-7123 to improve lung function in COPD. The podcast is moderated by AJRCCM podcast editor, Nitin Seam.

Further episodes of Out of the Blue: An AJRCCM Podcast

Further podcasts by American Thoracic Society

Website of American Thoracic Society